A CYP1B1 inhibitor
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

DMU2105

Item No. 38522

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
3-(2-naphthalenyl)-1-(3-pyridinyl)-2-propen-1-one
CAS Number
1031063-36-1
Molecular Formula
C18H13NO
Formula Weight
259.3
Purity
≥98%
Formulation
A solid
Solubility(Learn about Variance in Solubility)
Methanol: Soluble
SMILES
O=C(C1=CN=CC=C1)C=CC2=CC3=C(C=CC=C3)C=C2
InChi Code
InChI=1S/C18H13NO/c20-18(17-6-3-11-19-13-17)10-8-14-7-9-15-4-1-2-5-16(15)12-14/h1-13H
InChi Key
VWBDGXJRQZDLRV-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    5 mg

    $74

    Add

    10 mg

    $132

    Add

    25 mg

    $238

    Add

    50 mg

    $403

    Add
    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    DMU2105 is an inhibitor of the cytochrome P450 (CYP) isoform CYP1B1 (IC50 = 0.01 µM).1 It is selective for CYP1B1 over CYP1A1, CYP1A2, CYP3A4, and CYP2D6 (IC50s = 0.742, 1.2, 18, and 10 µM, respectively). DMU2105 enhances cisplatin-induced cell death in HEK293 cells overexpressing CYP1B1.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Horley, N.J., Beresford, K.J.M., Chawla, T., et al. Discovery and characterization of novel CYP1B1 inhibitors based on heterocyclic chalcones: Overcoming cisplatin resistance in CYP1B1-overexpressing lines. Eur. J. Med. Chem. 129, 159-174 (2017).